Clinical Trial Update: Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing trigger-based ablation with substrate-based ablation for paroxysmal atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED